Skip to main content

Table 3 Linear regression analysis for prediction of LVEF

From: Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis

Variable

Multivariate analysis

Coefficient (95% confidence interval)

P

Anti-MCV

−0.006 (− 0.009_ − 0.003)

<0.001

Age (year)

−0.111 (− 0.186_ − 0.037)

0.004

Constant

63.604 (59.577_67.632)

<0.001

  1. Anti-MCV Anti-modified citrullinated vimentin